Search Results
Site Search
Autoimmune profile updates - Insights
Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
A Test in Focus Archives - Page 4 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Post-Bulletin Features Dr. Bobbi Pritt's "Creepy, Dreadful, Wonderful Parasites" Blog - Insights
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.
Frequently asked questions - Insights
Check out how chromosomal microarray testing at Mayo Clinic Laboratories can help optimize treatment for neurological tumors.
Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Identifying a precise genetic cause of hearing loss impacts clinical management. Nicole Boczek, Ph.D., and Melanie Meyer, M.S., CGC, explain how Mayo Clinic Laboratories' updated panel yields comprehensive results for optimal patient care.
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
Carrier Screening [Test in Focus] - Insights
Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for...
Urinary ammonium testing - Insights
John Lieske, M.D., discusses Mayo Clinic Laboratories' urinary ammonium testing. A test that takes the guesswork out of determining acid base disorders by giving nephrologists a true understanding of a patient’s true urinary ammonium level.
Enhanced detection of genetic mutation to optimize leukemia treatment - Insights
Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical...
The seven S's of connectivity impact - Insights
With many organizations using a digital-first approach, it is easy to assume that is always the best option. But is it? And what about for your laboratory outreach program? Laboratories should consider these seven S’s when deciding whether...
Comprehensive panel boosts GIST diagnosis sensitivity - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Novel biomarkers added to movement disorders profile - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
MayoComplete Solid Tumor Panel - Insights
Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.
West Nile virus [Test in Focus] - Insights
Bobbi Pritt, M.D., discusses how Mayo Clinic Labs’ updated PCR assay for West Nile virus provides increased sensitivity to detect virus RNA in multiple sources, identifies two virus lineages, and confirms diagnosis.
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
A web of care, close to home: Support on the cancer journey - Insights
Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was...
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights
An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...
Personal journey shapes unique perspective: Linda Hasadsri, M.D., Ph.D. - Insights
Dr. Linda Hasadsri’s firsthand encounter with the genetic tests she’s helped develop has provided rare insight into testing quality and implications, enhancing their ability to advocate for the value of testing and infusing their work with...
An emotional proposition for a pancreatic cancer survivor: Jim Smith - Insights
Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully,...
Mayo Clinic Labs @Work: Ona Saras - Insights
As a clinical specialty representative, Ona Saras’ decade-long dedication to patient care and advocacy for cutting-edge testing at Mayo Clinic Laboratories has transformed lives across Northern California and Reno, Nevada. Through personal...
Thankful for Tygh: The Derossett Family - Insights
A Mayo Clinic Laboratories newborn screening panel detects a rare disease and paves the way for life-sustaining treatment.
Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...
Widening the net to capture elusive pathogens - Insights
Central nervous system infections, such as meningitis and encephalitis, can be devastating for affected patients. While specific treatments are available for some of these infections, it first requires identifying the precise cause of...
Modified two-tiered testing for Lyme disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
Sorting through the Details of an Automation Solution - Insights
Laboratories face increasing pressure to automate their operations as they are challenged by a continuing increase in workload, a need to reduce expenditure, and a demand for accuracy and improved turnaround time—essentially doing more with...
Morris Hospital & Healthcare Centers: Expanding diagnostic care in a rural community - Insights
By collaborating with Mayo Clinic Laboratories, Morris Hospital & Healthcare Center has been able to expand complex and specialized lab testing in the communities they serve.
Liver Disease Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
Malabsorption panel: Filling a gap in pediatric care - Insights
Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
At Mayo Clinic Laboratories, familial variant analysis can clarify genetic variants in family members when a variant of interest has been previously identified.
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
Improving outcomes through comprehensive controlled substance monitoring - Insights
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...
Lymphomas Testing - Mayo Clinic Laboratories
To assist clinicians with lymphoma diagnosis, Mayo Clinic has a highly experienced, 9-member hematopathology section focusing on lymphoma diagnosis, which diagnoses more than 3,000 lymphoma cases per year.
December 2023 - Gastroenterology Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
November 2023 - Gastroenterology Pathology Case 1 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
Medication-targeted testing - Insights
Learn more about how medication targeted testing at Mayo Clinic Laboratories can assist in treatment optimization for medication with established pharmacogenomic associations.
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Bile acid malabsorption - Insights
Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...
July 2023 - Breast Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
August 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
A Test in Focus Archives - Page 3 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
A Test in Focus Archives - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...